| Literature DB >> 29416067 |
Claudia Kalbe1, Manuela Zebunke2,3, Dorothea Lösel4,5, Julia Brendle6,7, Steffen Hoy6, Birger Puppe8,9.
Abstract
Self-determined physical activity is an essential behavioural need and can vary considerably between individuals of a given species. Although locomotion is suggested as a prerequisite for adequate function of skeletal muscle, domestic pigs are usually reared under limited space allowance. The aim of our study was to investigate if a different voluntary locomotor activity leads to altered properties in the muscle structure, biochemistry and mRNA expression of selected genes involved in myogenesis and skeletal muscle metabolism. Based on a video tracking method, we assigned pigs to three categories according to their total distances walked over five observed time points: long distance, medium distance, and short distance. The microstructure and biochemistry parameters of the M. semitendinosus were unaffected by the distance categories. However, we found distance-dependent differences in the mRNA expression of the genes encoding growth (IGF2, EGF, MSTN) and transcription factors (MRF4, MYOD). In particular, the IGF2/MSTN ratio appears to be a sensitive indicator, at the molecular level, for the locomotor activity of individuals. Our results indicate that the myogenic growth potential of pigs under standard rearing conditions is triggered by their displayed voluntary locomotor activity, but the covered distances are insufficient to induce adaptive changes at the tissue level.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29416067 PMCID: PMC5803246 DOI: 10.1038/s41598-018-20652-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Experimental design for monitoring the individual voluntary locomotor activity of the focus animals. At five different ontogenetic time points the pigs were observed via video camera for 48 h each. The daily distances of each focus pig were analysed using the VideoMotionTracker® according to Brendle and Hoy[8] and summed over the time points. All focus animals were assigned to the distance categories of short, medium or long distances (n = 4, each).
Figure 2Development of the daily distance walked by the pigs for the three distance categories over five different time points (lsmeans, n = 12 focus animals; LD = long distance, MD = medium distance, SD = short distance). Lines indicate the calculated regression lines of each distance category over the different time points (solid line = LD animals: y = 1148.0x − 142.4, r² = 0.475; dashed line = MD animals: y = 878.0x − 101.5, r² = 0.560; dotted line = SD animals: y = 723.6x − 86.8, r² = 0.517).
Microstructural properties analysed in M. semitendinosus from focus pigs for the three distance categories (lsmeans ± SE, n = 12).
| Property | long distance | medium distance | short distance | F | P |
|---|---|---|---|---|---|
| TFN (thousands) | 953 ± 34 | 880 ± 34 | 895 ± 34 | 1.27 | 0.332 |
| Capillaries/fibre | 0.32 ± 0.06 | 0.43 ± 0.06 | 0.30 ± 0.06 | 1.46 | 0.287 |
| Fibre area/capillary (µm²) | 11,769 ± 1,491 | 9,890 ± 1,495 | 13,571 ± 1,483 | 1.52 | 0.275 |
| FCSA (µm²) | |||||
| STO | 4,049 ± 448 | 4,384 ± 449 | 4,887 ± 446 | 0.90 | 0.446 |
| FTO | 3,222 ± 337 | 4,036 ± 338 | 3,696 ± 336 | 1.45 | 0.291 |
| FTG | 3,468 ± 212 | 3,553 ± 213 | 3,627 ± 211 | 0.14 | 0.870 |
| Pathologic | 2,605 ± 609 | 1,678 ± 684 | 1,435 ± 706 | 0.88 | 0.464 |
| Average | 3,456 ± 269 | 3,847 ± 270 | 3,864 ± 268 | 0.73 | 0.511 |
| Relative fibre number (%) | |||||
| STO | 20.1 ± 2.6 | 22.2 ± 2.6 | 17.2 ± 2.6 | 0.90 | 0.443 |
| FTO | 28.1 ± 1.4 | 28.7 ± 1.4 | 29.5 ± 1.4 | 0.25 | 0.784 |
| FTG | 49.7 ± 1.8 | 47.9 ± 1.8 | 52.4 ± 1.8 | 1.53 | 0.273 |
| Pathologic | 2.2 ± 0.7 | 1.2 ± 0.7 | 0.9 ± 0.7 | 1.05 | 0.395 |
TFN – total fibre number; FCSA – fibre cross-sectional area; STO – slow twitch oxidative; FTO – fast twitch oxidative; FTG – fast twitch glycolytic.
Biochemical properties analysed in M. semitendinosus from focus pigs for the three distance categories (lsmeans ± SE, n = 12).
| Property | long distance | medium distance | short distance | F | P |
|---|---|---|---|---|---|
| Total DNA (mg) | 273.71 ± 19.01 | 293.31 ± 19.06 | 304.02 ± 18.90 | 0.66 | 0.544 |
| Total RNA (mg) | 165.08 ± 9.79 | 176.89 ± 9.81 | 167.82 ± 9.73 | 0.39 | 0.688 |
| Total protein (g) | 52.55 ± 3.39 | 55.67 ± 3.39 | 56.58 ± 3.37 | 0.39 | 0.690 |
| ICDH (IU/g protein) | 16.13 ± 1.10 | 15.75 ± 1.10 | 14.70 ± 1.09 | 0.46 | 0.648 |
| LDH (IU/mg protein) | 3.32 ± 0.13 | 3.42 ± 0.13 | 3.54 ± 0.13 | 0.70 | 0.523 |
| CK (IU/mg protein) | 26.11 ± 0.98 | 26.20 ± 0.98 | 26.63 ± 0.98 | 0.08 | 0.924 |
ICDH–isocitrate dehydrogenase, LDH – lactate dehydrogenase, CK – creatine kinase.
Total DNA, RNA, and protein = concentration × muscle weight.
mRNA expression of selected genes analysed in M. semitendinosus from focus pigs for the three distance categories (lsmeans ± SE, n = 12).
| Gene | long distance | medium distance | short distance | F | P |
|---|---|---|---|---|---|
| myogenic transcription factors | |||||
| PAX7 | 1.14 ± 0.09 | 1.23 ± 0.09 | 1.03 ± 0.09 | 1.29 | 0.328 |
| MYF5 | 0.99 ± 0.14 | 0.69 ± 0.14 | 0.78 ± 0.14 | 1.21 | 0.347 |
| MYOD | 1.66 ± 0.32 AB | 2.61 ± 0.32A | 1.54 ± 0.32B | 3.32 | 0.089 |
| MYOG | 1.26 ± 0.18 | 0.86 ± 0.18 | 1.17 ± 0.17 | 1.39 | 0.304 |
| MRF4 | 0.65 ± 0.13ab | 0.51 ± 0.13a | 1.03 ± 0.13b | 4.47 | 0.049 |
| growth factors and growth factor receptors | |||||
| BDNF | 0.43 ± 0.22 | 0.64 ± 0.22 | 0.67 ± 0.22 | 0.35 | 0.713 |
| MSTN | 0.36 ± 0.08aAB | 0.53 ± 0.08abA | 0.84 ± 0.08bB | 9.16 | 0.009 |
| IGF1 | 1.45 ± 0.17 | 1.65 ± 0.17 | 1.39 ± 0.17 | 0.65 | 0.546 |
| IGF2 | 1.22 ± 0.09a | 1.01 ± 0.09ab | 0.80 ± 0.09b | 5.63 | 0.030 |
| EGF | 0.52 ± 0.14a | 0.63 ± 0.14ab | 1.06 ± 0.14b | 4.52 | 0.048 |
| AREG | 0.51 ± 0.24 | 0.42 ± 0.24 | 0.87 ± 0.23 | 1.03 | 0.401 |
| IGFBP5 | 0.89 ± 0.12 | 0.82 ± 0.12 | 1.07 ± 0.12 | 1.07 | 0.389 |
| IGF1R | 1.00 ± 0.10 | 1.23 ± 0.10 | 1.14 ± 0.10 | 1.24 | 0.341 |
| EGFR | 0.82 ± 0.14 | 0.90 ± 0.14 | 1.02 ± 0.14 | 0.54 | 0.603 |
| GHR | 0.66 ± 0.09 | 0.80 ± 0.09 | 0.90 ± 0.09 | 1.70 | 0.242 |
| muscle structure and metabolism associated genes | |||||
| PRKAA2 | 0.94 ± 0.14 | 1.04 ± 0.14 | 1.21 ± 0.14 | 0.96 | 0.424 |
| SLN | 0.89 ± 0.18 | 0.56 ± 0.18 | 0.91 ± 0.18 | 1.17 | 0.357 |
| GATM | 0.62 ± 0.21 | 0.66 ± 0.21 | 0.94 ± 0.20 | 0.71 | 0.522 |
| CKM | 0.90 ± 0.14 | 0.66 ± 0.14 | 0.75 ± 0.14 | 0.74 | 0.506 |
| MYOT | 0.90 ± 0.13 | 0.81 ± 0.13 | 0.85 ± 0.13 | 0.09 | 0.913 |
| SORBS1 | 1.03 ± 0.19 | 0.95 ± 0.19 | 1.06 ± 0.19 | 0.10 | 0.908 |
Data are expressed as arbitrary units after normalisation by the endogenous reference gene HPRT1. AREG - amphiregulin; BDNF – brain derived neurotrophic factor; CKM - creatine kinase, M-type; EGF – epidermal growth factor; EGFR - epidermal growth factor receptor; GATM - glycine amidinotransferase; GHR – growth hormone receptor; IGF1, 2 – insulin-like growth factor 1, 2; IGFBP5 - insulin growth factor binding protein 5; IGF1R - insulin-like growth factor 1 receptor; MRF4 - muscle-specific regulatory factor 4; MSTN – myostatin; MYF5 – myogenic factor 5; MYOD - myogenic differentiation factor; MYOG – myogenin; MYOT - myotilin; PAX7 – paired box transcription factor 7; PRKAA2 - AMP-activated protein kinase catalytic sub-unit alpha-2; SLN – sarcolipin; SORBS1 – sorbin and SH3 domain containing 1.
Labelled least squares means within a row with different lower-case letters differ (P ≤ 0.05) or with upper-case letters tend to differ (P ≤ 0.10).
Figure 3Relationship between the total distance walked by the pigs and the ratios between the mRNA expression of IGF2 and MSTN (black dots, n = 12 focus animals; IGF2 – insulin-like growth factor 2, MSTN – myostatin; rS indicates the Spearman rank correlation coefficient and P the corresponding significance).
Primers used for qPCR.
| Gene | Accession no. or reference | Forward primer | Reverse primer | Size (bp) | TA (°C) |
|---|---|---|---|---|---|
| AREG | NM_214376 | GCCATTGCTGCTTTTGTCTCTGCC | TGGCAGTGACCCCGATCTGCT | 198 | 60 |
| BDNF | Solberg | AGCGTGTGCGACAGCATTAG | GTCCACTGCCGTCTTTTTATCC | 60 | 58 |
| CKM | Seale | GCAAGCACCCCAAGTTTGA | ACCTGTGCCGCGCTTCT | 62 | 55 |
| EGF | Kennedy | TCTGAACCCGGACGGATTTG | GACATCGCTCGCGAACGTAG | 202 | 60 |
|
| Kalbe | TGGAGAAGCTCCCAACCA | CTCTTAATTCCTTGATAGCCACAG | 161 | 60 |
| GATM | NM_001128442 | GGCAGCTTGAGATGTTGATCC | TCACCAGTGTTGAGATGAGAGT | 256 | 60 |
| GHR | Rehfeldt | TGATTCTACCCCCAGTTCCAGTTC | TCAGTCTTTTCATCAGGGTCATCA | 187 | 56 |
| HPRT1 | Erkens | CCGAGGATTTGGAAAAGGT | CTATTTCTGTTCAGTGCTTTGATGT | 181 | 59 |
| IGF1 | Kalbe | CTCTTCGCATCTCTTCTACTTGGC | CCTGTGGGCTTGTTGAAATAAAA | 150 | 60 |
| IGF2 | Kalbe | TGGCATCGTGGAAGAGTG | AGGTGTCATAGCGGAAGAAC | 164 | 57 |
| IGFBP5 | Rehfeldt | GTGTACCTGCCCAACTGTGA | AAGCTGTGGCACTGGAAGTC | 158 | 56 |
| IGF1R | Kalbe | GATTCAGGCCACCTCTCTCTCC | CCCTCCTACTATCAACAGAACGGC | 139 | 60 |
| MRF4 | Maak | CGCCATCAACTACATCGAGAGGT | ATCACGAGCCCCCTGGAAT | 189 | 60 |
| MSTN | Maak | CCCGTCAAGACTCCTACAACA | CACATCAATGCTCTGCCAA | 141 | 62 |
| MYF5 | Rehfeldt | CCTGAATGCAACAGCCCT | CGGAGTTGCTGATCCGAT | 152 | 60 |
| MYOD | Rehfeldt | GGTGACTCAGACGCATCCA | ATAGGTGCCGTCGTAGCAGT | 108 | 60 |
| MYOG | Rehfeldt | CAACCAGGAGGAGCGAGAC | AGGGTCAGCTGTGAGCAGAT | 161 | 64 |
| MYOT | NM_001099941 | GGCTCGCAGATTGCTAGGACCA | GCTGTGGTGAATCTTGTGCGGC | 83 | 60 |
| PAX7 | Patruno | CAACCACATCCGCCACAA | TCTTGGAGACACAGCCATGG | 101 | 58 |
| PRKAA2 | Kalbe | TGACCCCCTGAAACGAGCAACTA | CAATGACAAGATGATAAGCCACTGC | 233 | 55 |
| SLN | NM_001044566 | GGCACCCCATAGCACTTCTGACC | GGCAGCCCTTGAGAGCAGCAT | 102 | 60 |
| SORBS1 | XM_001924661 | CCACTGCAAGCCCTCAGCCTT | GTGACTCTTCGCTGCTGGGCT | 106 | 65 |
TA, annealing temperature; AREG - amphiregulin; BDNF – brain derived neurotrophic factor; CKM - creatine kinase, M-type; EGF – epidermal growth factor; EGFR - epidermal growth factor receptor; GATM - glycine amidinotransferase; GHR – growth hormone receptor; HPRT1 - hypoxanthine phosphoribosyltransferase 1; IGF1, 2 – insulin-like growth factor 1, 2; IGFBP5 - insulin growth factor binding protein 5; IGF1R - insulin-like growth factor 1 receptor; MRF4 - muscle-specific regulatory factor 4; MSTN – myostatin; MYF5 – myogenic factor 5; MYOD - myogenic differentiation factor; MYOG – myogenin; MYOT - myotilin; PAX7 – paired box transcription factor 7; PRKAA2 - AMP-activated protein kinase catalytic sub-unit alpha-2; SLN – sarcolipin; SORBS1 – sorbin and SH3 domain containing 1.